|
1
|
Zhang XD, Wang Y and Ye LH: Hepatitis B
virus X protein accelerates the development of hepatoma. Cancer
Biol Med. 11:182–190. 2014.PubMed/NCBI
|
|
2
|
Buendia MA and Neuveut C: Hepatocellular
carcinoma. Cold Spring Harb Perspect Med. 5:pp. a0214442015,
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Park NH, Song IH and Chung YH: Molecular
pathogenesis of Hepatitis-B-virus-associated hepatocellular
carcinoma. Gut Liver. 1:101–117. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Seeger C and Mason WS: Hepatitis B virus
biology. Microbiol Mol Biol Rev. 64:51–68. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Minor MM and Slagle BL: Hepatitis B virus
HBx protein interactions with the ubiquitin proteasome system.
Viruses. 6:4683–4702. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tang H, Oishi N, Kaneko S and Murakami S:
Molecular functions and biological roles of hepatitis B virus x
protein. Cancer Sci. 97:977–983. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ali A, Abdel-Hafiz H, Suhail M, Al-Mars A,
Zakaria MK, Fatima K, Ahmad S, Azhar E, Chaudhary A and Qadri I:
Hepatitis B virus, HBx mutants and their role in hepatocellular
carcinoma. World J Gastroenterol. 20:10238–10248. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
He Q, Li W, Ren J, Huang Y, Huang Y, Hu Q,
Chen J and Chen W: ZEB2 inhibits HBV transcription and replication
by targeting its core promoter. Oncotarget. 7:16003–16011.
2016.PubMed/NCBI
|
|
9
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
10
|
Comijn J, Berx G, Vermassen P, Verschueren
K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D and van Roy
F: The two-handed E box binding zinc finger protein SIP1
downregulates E-cadherin and induces invasion. Mol Cell.
7:1267–1278. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Behrens J, Löwrick O, Klein-Hitpass L and
Birchmeier W: The E-cadherin promoter: Functional analysis of a
G.C-rich region and an epithelial cell-specific palindromic
regulatory element. Proc Natl Acad Sci USA. 88:11495–11499. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Giroldi LA, Bringuier PP, de Weijert M,
Jansen C, van Bokhoven A and Schalken JA: Role of E boxes in the
repression of E-cadherin expression. Biochem Biophys Res Commun.
241:453–458. 1997. View Article : Google Scholar
|
|
13
|
Martin-Lluesma S, Schaeffer C, Robert EI,
van Breugel PC, Leupin O, Hantz O and Strubin M: Hepatitis B virus
X protein affects S phase progression leading to chromosome
segregation defects by binding to damaged DNA binding protein 1.
Hepatology. 48:1467–1476. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Arbuthnot P, Capovilla A and Kew M:
Putative role of hepatitis B virus X protein in
hepatocarcinogenesis: Effects on apoptosis, DNA repair,
mitogen-activated protein kinase and JAK/STAT pathways. J
Gastroenterol Hepatol. 15:357–368. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kew MC: Hepatitis B virus x protein in the
pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
J Gastroenterol Hepatol. 26(Suppl 1): pp. S144–S152. 2011,
View Article : Google Scholar
|
|
16
|
Shin Kim S, Yeom S, Kwak J, Ahn HJ and Lib
Jang K: Hepatitis B virus X protein induces epithelial-mesenchymal
transition by repressing E-cadherin expression via upregulation of
E12/E47. J Gen Virol. 97:134–143. 2016. View Article : Google Scholar
|
|
17
|
Chen X, Bode AM, Dong Z and Cao Y: The
epithelial-mesenchymal transition (EMT) is regulated by oncoviruses
in cancer. FASEB J. 30:3001–3010. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang J, Mani SA, Donaher JL, Ramaswamy S,
Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A and
Weinberg RA: Twist, a master regulator of morphogenesis, plays an
essential role in tumor metastasis. Cell. 117:927–939. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cobaleda C, Pérez-Caro M, Vicente-Dueñas C
and Sánchez-García I: Function of the zinc-finger transcription
factor SNAI2 in cancer and development. Annu Rev Genet. 41:41–61.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
van Grunsven LA, Michiels C, Van de Putte
T, Nelles L, Wuytens G, Verschueren K and Huylebroeck D:
Interaction between Smad-interacting protein-1 and the corepressor
C-terminal binding protein is dispensable for transcriptional
repression of E-cadherin. J Biol Chem. 278:26135–26145. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Verschueren K, Remacle JE, Collart C,
Kraft H, Baker BS, Tylzanowski P, Nelles L, Wuytens G, Su MT,
Bodmer R, et al: SIP1, a novel zinc finger/homeodomain repressor,
interacts with Smad proteins and binds to 5′-CACCT sequences in
candidate target genes. J Biol Chem. 274:20489–20498. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Remacle JE, Kraft H, Lerchner W, Wuytens
G, Collart C, Verschueren K, Smith JC and Huylebroeck D: New mode
of DNA binding of multi-zinc finger transcription factors: deltaEF1
family members bind with two hands to two target sites. EMBO J.
18:5073–5084. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lerchner W, Latinkic BV, Remacle JE,
Huylebroeck D and Smith JC: Region-specific activation of the
Xenopus brachyury promoter involves active repression in ectoderm
and endoderm: A study using transgenic frog embryos. Development.
127:2729–2739. 2000.PubMed/NCBI
|
|
25
|
van Grunsven LA, Schellens A, Huylebroeck
D and Verschueren K: SIP1 (Smad interacting protein 1) and deltaEF1
(delta-crystallin enhancer binding factor) are structurally similar
transcriptional repressors. J Bone Joint Surg Am. 83-A(Suppl 1):
pp. S40–S47. 2001
|
|
26
|
Ropero S and Esteller M: The role of
histone deacetylases (HDACs) in human cancer. Mol Oncol. 1:19–25.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yoo YG, Na TY, Seo HW, Seong JK, Park CK,
Shin YK and Lee MO: Hepatitis B virus X protein induces the
expression of MTA1 and HDAC1, which enhances hypoxia signaling in
hepa-tocellular carcinoma cells. Oncogene. 27:3405–3413. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shon JK, Shon BH, Park IY, Lee SU, Fa L,
Chang KY, Shin JH and Lee YI: Hepatitis B virus-X protein recruits
histone deacety-lase 1 to repress insulin-like growth factor
binding protein 3 transcription. Virus Res. 139:14–21. 2009.
View Article : Google Scholar
|
|
29
|
Aghdassi A, Sendler M, Guenther A, Mayerle
J, Behn CO, Heidecke CD, Friess H, Büchler M, Evert M, Lerch MM and
Weiss FU: Recruitment of histone deacetylases HDAC1 and HDAC2 by
the transcriptional repressor ZEB1 downregulates E-cadherin
expression in pancreatic cancer. Gut. 61:439–448. 2012. View Article : Google Scholar
|
|
30
|
Schneider G, Krämer OH and Saur D: A
ZEB1-HDAC pathway enters the epithelial to mesenchymal transition
world in pancreatic cancer. Gut. 61:329–330. 2012. View Article : Google Scholar
|
|
31
|
Srisuttee R, Koh SS, Kim SJ, Malilas W,
Boonying W, Cho IR, Jhun BH, Ito M, Horio Y, Seto E, et al:
Hepatitis B virus X (HBX) protein upregulates β-catenin in a human
hepatic cell line by sequestering SIRT1 deacetylase. Oncol Rep.
28:276–282. 2012.PubMed/NCBI
|
|
32
|
Shen L, Zhang X, Hu D, Feng T, Li H, Lu Y
and Huang J: Hepatitis B virus X (HBx) play an anti-apoptosis role
in hepatic progenitor cells by activating Wnt/β-catenin pathway.
Mol Cell Biochem. 383:213–222. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xie Q, Chen L, Shan X, Shan X, Tang J,
Zhou F, Chen Q, Quan H, Nie D, Zhang W, et al: Epigenetic silencing
of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma
cell tumorigenicity through Wnt signaling pathway. Int J Cancer.
135:635–646. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Arzumanyan A, Friedman T, Kotei E, Ng IO,
Lian Z and Feitelson MA: Epigenetic repression of E-cadherin
expression by hepatitis B virus x antigen in liver cancer.
Oncogene. 31:563–572. 2012. View Article : Google Scholar
|
